The Drugs Technical Advisory Board (DTAB) has recommended amendment of the Rules to change Allergan India’s Refresh Tears eye drops from prescription drug to over-the-counter drug, in line with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback